Multiple sclerosis (Houndmills, Basingstoke, England)

Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension.

Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis.

Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.

Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years.

A smartphone sensor-based digital outcome assessment of multiple sclerosis.

An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis.

A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study.

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.

Harnessing electronic medical records to advance research on multiple sclerosis.

Pages